+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Spasmolytic effect of mebeverine on the gastrointestinal motility



Spasmolytic effect of mebeverine on the gastrointestinal motility



Il Farmaco; Edizione Scientifica 30(10): 823-836



Mebeverine, N-ethyl-4'-[1-methyl-2-(4-methoxyphenyl)ethylamino] butyl-3,4-dimetoxybenzoate, was studied for its inhibitory effect on the motility of the gastrointestinal tract in vivo and in vitro. In both cases its activity was more evident on the hypermotility induced by some common physiological spasmogenic agents than on basal motility. In various tests it was ascertained that mebeverine was able to inhibit the stimulant actions of all the drugs employed, both those acting on specific receptor sites such as histamine and acetylcholine, and those acting directly on the smooth muscle such as substance P, physalaemin etc. This backs up the suggestion of a nonspecific miotropic effect of mebeverine. This compound has the same spasmolytic action at different levels of the gastrointestinal tract and is decisively stronger than papaverine. The lack of remarkable side-effects in the tests which were carried out in vivo with decisively active doses on the gastrointestinal motility and the good inhibitory effect on human isolated strips of the gastrointestinal tract suggest that mebeverine may be useful in the treatment of clinical morbid conditions characterized by hypertone or hypermotility of the gastrointestinal tract.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041402123

Download citation: RISBibTeXText

PMID: 1183600


Related references

Mebeverine a gastrointestinal spasmolytic drug acting through opiate and serotonergic receptors. Gastroenterology 96(5 PART 2): A418, 1989

Spasmolytic effect of octylonium bromide on gastrointestinal motility in vitro. Il Farmaco; Edizione Pratica 35(5): 258-264, 1980

The influence of spasmolytic agents on heart rate variability and gastrointestinal motility in normal horses. Research in Veterinary Science 93(3): 1426-1433, 2013

The effect of an ispaghula mebeverine combination on colonic motility patterns in normal subjects. Gastroenterology 88(5 PART 2): 1554, 1985

Effect of mebeverine hydrochloride on jejunal motility and epithelial transport in the anesthetized ferret. Gastroenterology 98(5 PART 2): A354, 1990

Contribution to the treatment of colonic diseases. (Apropos of the uses of a new synthetic spasmolytic drug, mebeverine hydrochloride). Revue des Corps de Sante des Armees Terre, Mer, Air 8(3): 349-358, 1967

Effect of site of delivery of mebeverine on bethanechol stimulated ileal and colonic motility in anesthetized ferrets. Gastroenterology 100(5 PART 2): A482, 1991

Formulation, in-vitro release and ex-vivo spasmolytic effects of mebeverine hydrochloride suppositories containing polycarbophil or polysorbate 80. International Journal Of Pharmaceutics (amsterdam). 142(2): 163-168, 1996

Gastrointestinal motility: a review. I. Smooth muscle as the basic mechanism of gastrointestinal motility. II. Gastric and duodenal motility and factors influencing them. Mededelingen van de Faculteit Diergeneeskunde Rijksuniversiteit Gent 21(3/4): 128, 1979

Roentgenological research on the effect of a new spasmolytic on the motility of the gallbladder. Medizinische Klinik 57: 1147-1150, 1962

Effect of spasmolytic analgesic drugs on the motility patterns of the equine small intestine. Research in Veterinary Science 34(3): 334-339, 1983

Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motility disorders. Neurogastroenterology and Motility 27(12): 1736-1746, 2016

Gastrointestinal motility studies in Scandinavia. Proceedings from the first scientific meeting of SAGIM. Scandinavian Association for Gastrointestinal Motility. Oslo, 1987. Scandinavian Journal of Gastroenterology. Supplement 152: 1-90, 1988

Motility disorders of the gastrointestinal tract. Highlights of the 1st European Postgraduate Course on Gastrointestinal Motility 10 to 13 June 1992 in Utrecht. Zeitschrift für Gastroenterologie 31 Suppl 1: 1-18, 1993

Identification of mebeverine acid as the main circulating metabolite of mebeverine in man. Journal of Pharmaceutical & Biomedical Analysis 29(1-2): 335-340, 30 June, 2002